Tagged With GILD Stock

Gilead tanks 9% on report its coronavirus drug doesn't help patients

Ben Winck

Apr 24, 2020, 4:44 AM

Arcus Biosciences spikes 99% on reports of $10 billion Gilead partnership

Ben Winck

Apr 17, 2020, 5:58 AM

One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now

Ben Winck

Mar 6, 2020, 3:55 AM

A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.

Ben Winck

Feb 29, 2020, 12:24 AM

Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus

Ben Winck

Feb 25, 2020, 5:20 AM